Imagen de cubierta local
Imagen de Google Jackets
Lung Cancer: New Understandings and Therapies / edited by Anne C. Chiang, Roy S. Herbst
Colaborador(es): Chiang, Anne C
| Herbst, Roy S | SpringerLink (Online service).
Tipo de material: 
E-bookSeries (Current Cancer Research, 2199-2584); (Medicine (Springer-11650)).Conjunto: Editor: Cham : Springer International Publishing, 2021Edición: 1st ed. 2021.Descripción: 1 recurso en línea (VI, 264 páginas) : 1 b/w illustrations, 16 illustrations in colour.ISBN: 9783030740283.Tema: Pulmones -- CáncerRecursos en línea: Acceso a este recurso digital (usuarios Universidad Europea de Valencia)
Resumen: Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach. For targeted and immunotherapeutic approaches, understanding the biology of acquired resistance is a key strategy that has yielded productive advances in the subsequent treatment. Future advances also include incorporating biomarker data obtained from solid and liquid biopsies, as well as combination of immunotherapy with radiotherapy and in special populations such patients with CNS involvement.
| Tipo de ítem | Biblioteca actual | Colección | Signatura topográfica | Estado | Fecha de vencimiento | Código de barras | Reserva de ítems | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Valencia Digital Acceso Electrónico (UEV) | Ciencias de la Salud | RC280 .L86 2021 EB (Navegar estantería(Abre debajo)) | Acceso electrónico |
Total de reservas: 0
Navegando Valencia Digital estanterías, Ubicación en estantería: Acceso Electrónico (UEV) Cerrar el navegador de estanterías (Oculta el navegador de estanterías)
| RC280.L8 .N35 2021 EB Malignant Pleural Mesothelioma : Advances in Pathogenesis, Diagnosis, and Treatments | RC280 L8 .T37 2019 EB Targeted Therapies for Lung Cancer | RC280 .L86 2018 EB Early-stage Lung Cancer: Screening and Management | RC280 .L86 2021 EB Lung Cancer: New Understandings and Therapies | RC280 .L9 2020 EB Novel Therapeutics for Rare Lymphomas | RC280 .L9 .D74 2021 EB Indolent Lymphomas | RC280 .L9 T34 2019EB T-Cell and NK-Cell Lymphomas : From Biology to Novel Therapies |
Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach. For targeted and immunotherapeutic approaches, understanding the biology of acquired resistance is a key strategy that has yielded productive advances in the subsequent treatment. Future advances also include incorporating biomarker data obtained from solid and liquid biopsies, as well as combination of immunotherapy with radiotherapy and in special populations such patients with CNS involvement.
No hay comentarios en este titulo.
Ingresar a su cuenta para colocar un comentario.
Haga clic en una imagen para verla en el visor de imágenes